GAGE HENRY: Open Payments
NPI 1366007841 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,945 in 103 payments from 28 companies in 2025. Trend: 2023 $2,559 · 2024 $2,582 · 2025 $1,945
Food & beverage: $1,945
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $545 |
| Novo Nordisk Inc | 15 | $194 |
| Otsuka America Pharmaceutical, Inc. | 6 | $149 |
| PFIZER INC. | 10 | $147 |
| GlaxoSmithKline, LLC. | 6 | $109 |
| Radius Health, Inc. | 3 | $90 |
| Dexcom, Inc. | 4 | $67 |
| Lilly USA, LLC | 4 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Lundbeck LLC | 3 | $56 |
Products named: UBRELVY, REXULTI, LINZESS, NURTEC ODT, TRELEGY ELLIPTA, VRAYLAR, Ozempic, Dexcom G6 Transmitter.
Industry payments across GA — which companies pay providers there.
